Target intelligence / Profile preview

ACTB pseudogene 12 (ACTBP12)

Target
ACTBP12
Molecular classification
Other (Pseudogene)
01

Overview

ACTB pseudogene 12 (ACTBP12) is a human pseudogene annotated by the HUGO Gene Nomenclature Committee as “ACTB pseudogene 12.” It does not encode a functional protein product but is a genomic DNA sequence highly similar to the functional actin beta (ACTB) or actin gamma (ACTG) genes. Pseudogenes like ACTBP12 have typically lost their protein-coding ability through evolution due to disruptive mutations or the absence of regulatory elements. As a result, ACTBP12 does not serve as a receptor, enzyme, transporter, or any other traditional therapeutic target, nor is it directly associated with any specific biological function or disease. It may have limited utility in genomics as a marker for evolutionary analyses or in studies addressing issues of pseudogene amplification in PCR experiments[5][9][8]. Key scientific points: - ACTBP12 is officially recognized as a pseudogene, not a protein-coding gene or receptor[5][9]. - It does not produce a protein, nor is it implicated in any disease or drug interactions as a direct target. - Pseudogenes, including ACTBP12, can complicate PCR experiments due to sequence similarity with functional genes, but have no established therapeutic relevance[4][8]. - The functional ACTB gene, not this pseudogene, encodes beta-actin, which is well characterized, but ACTBP12 is only a non-functional genomic element[1][2][3][6].

Other names
ACTGP5actin, beta pseudogene 12actin, gamma pseudogene 5

Beyond the preview

Go deeper on ACTB pseudogene 12 (ACTBP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTB pseudogene 12 (ACTBP12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call